Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 661, Issue 1-2, 2009, Pages 78-84

  Figl, Adina ^a   Scherer, Dominique ^a   Nagore, Eduardo ^b   Bermejo, Justo Lorenzo ^a   Dickes, Elke ^a   Thirumaran, Ranjit K ^a   Gast, Andreas ^a   Hemminki, Kari ^a,c   Kumar, Rajiv ^a   Schadendorf, Dirk ^a,d,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

APEX1; Melanoma; Polymorphisms; Progression; Survival; XRCC1

Indexed keywords

XRCC1 PROTEIN;

ADULT; AGED; APEX1 GENE; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS;

EID: 58549098021     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.11.011     Document Type: Article

References (23)

1. Buettner P.G., Leiter U., Eigentler T.K., and Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 103 (2005) 616-624
2. Lasithiotakis K.G., Leiter U., Eigentler T., Breuninger H., Metzler G., Meier F., and Garbe C. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?. Cancer 109 (2007) 1174-1182
3. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513-1530
4. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., Vineis P., and Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164 (2006) 297-302
5. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162 (2005) 925-942
6. Clarkson S.G., and Wood R.D. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 4 (2005) 1068-1074
7. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., Vahter M., Leonardi G.S., Clemens F., Fletcher T., Hemminki K., and Kumar R. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27 (2006) 1676-1681
8. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkstrom H., Larsson P., Kumar R., and Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
9. Hunter K. Host genetics influence tumour metastasis. Nat Rev Cancer 6 (2006) 141-146
10. Bolufer P., Barragan E., Collado M., Cervera J., Lopez J.A., and Sanz M.A. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30 (2006) 1471-1491
11. MacAuley A., and Ladiges W.C. Approaches to determine clinical significance of genetic variants. Mutat Res 573 (2005) 205-220
12. Kauffmann A., Rosselli F., Lazar V., Winnepenninckx V., Mansuet-Lupo A., Dessen P., van den Oord J.J., Spatz A., and Sarasin A. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 27 (2008) 565-573
13. Weaver D.A., Crawford E.L., Warner K.A., Elkhairi F., Khuder S.A., and Willey J.C. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer 4 (2005) 18
14. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., and Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
15. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De Palma G., Soucek P., and Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 28 (2007) 657-664
16. Moreno V., Gemignani F., Landi S., Gioia-Patricola L., Chabrier A., Blanco I., Gonzalez S., Guino E., Capella G., and Canzian F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12 (2006) 2101-2108
17. Bewick M.A., Conlon M.S., and Lafrenie R.M. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 24 (2006) 5645-5651
18. Sreeja L., Syamala V.S., Syamala V., Hariharan S., Raveendran P.B., Vijayalekshmi R.V., Madhavan J., and Ankathil R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 134 (2008) 645-652
19. Liu D., O'Day S.J., Yang D., Boasberg P., Milford R., Kristedja T., Groshen S., and Weber J. Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. Clin Cancer Res 11 (2005) 1237-1246
20. Li D., Li Y., Jiao L., Chang D.Z., Beinart G., Wolff R.A., Evans D.B., Hassan M.M., and Abbruzzese J.L. Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int J Cancer 120 (2007) 1748-1754
21. Downing A., Yu X.Q., and Newton-Bishop J.D. Forman Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 123 (2008) 861-866
22. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., Fleming I.D., Gershenwald J.E., Houghton Jr. A., Kirkwood J.M., McMasters K.M., Mihm M.F., Morton D.L., Reintgen D.S., Ross M.I., Sober A., Thompson J.A., and Thompson J.F. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
23. Hao B., Miao X., Li Y., Zhang X., Sun T., Liang G., Zhao Y., Zhou Y., Wang H., Chen X., Zhang L., Tan W., Wei Q., Lin D., and He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 25 (2006) 3613-3620